ALNYLAM PHARMACEUTICALS INC 20/05/2026 AGM
1a.Election of Class I Director of Alnylam to serve for a term ending in 2029: Stuart A. Arbuckle For
1b.Election of Class I Director of Alnylam to serve for a term ending in 2029: Yvonne L. Greenstreet, M.D. For
1c.Election of Class I Director of Alnylam to serve for a term ending in 2029: Elliott Sigal M.D., Ph.D. Oppose
2.Advisory Vote on Executive CompensationOppose
3.To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2026. Oppose